RecruitingNCT07583563

An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

A Multi-Center, Multinational, Observational Study of Octreotide Subcutaneous Depot for the Treatment of Patients With Acromegaly

Sponsor

Camurus AB

Enrollment

200 participants

Start Date

Jun 5, 2026

Study Type

OBSERVATIONAL

Conditions

Acromegaly

Summary

The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Octreotide subcutaneous depot for people with acromegaly. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.